Aprea Therapeutics Inc (APRE) Price Prediction & ForecastAPREAprea Therapeutics Inc

Alphio's APRE stock price prediction model matches the current Aprea Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.52 (-1.10%). The 1-week path is $0.52 (-2.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Aprea Therapeutics Inc is a good buy right now due to its recent price increase of 8.96% over the last five days, indicating positive momentum. The stock's current price is $0.53, which is significantly below its 52-week high of $1.49, suggesting potential for upside. Additionally, the company has a strong cash position of $46.5 million as of March 31, 2026, which is expected to sustain operations until Q1 2028, reducing financial risk. However, the main risk is the ongoing negative earnings trend, with a reported EPS of -0.09 in the last quarter, which reflects continued losses.

Aprea Therapeutics Inc (APRE) last closed at $0.528, gaining +6.60%. These facts feed the 1-day and 1-week APRE price prediction above.